Prozac® is associated with sudden harmful acts against oneself and others. The Food and Drug Administration (FDA) approved Prozac® in 1987 as a treatment option for depression, and it is also prescribed to treat obsessive-compulsive disorder and bulimia nervosa. Prozac® became widely popular because it caused fewer side effects than the commonly prescribed tricyclic antidepressants (TCAs), such as imipramine, of the time.

While some side effects of Prozac® would merely be considered nuisances, more frightening adverse reactions to the drug have been reported. Prozac® users and their families have reported patients committing numerous sudden acts of violence against themselves and others; many of these patients had no prior history of this type of behavior.

Prozac® is subject to the same black box warning as many antidepressants marketed in the United States. The warning, mandated by the FDA in the fall of 2004, informs physicians and consumers of the possibility of increased suicidality (suicidal thoughts and tendencies) in patients (particularly children and teens.)

A study found that growing mice exposed to Prozac® for as little as several weeks experienced an average of 9.4% less thighbone formation compared to mice who were not exposed to Prozac®. Researchers believe that Prozac® may cause cellular mechanisms that are an integral part of bone growth to shut down. Experts agree that further research is necessary to determine potential damage on human bones, especially those of children, whose bones are still growing. Prozac® is the only antidepressant approved by the FDA to treat Major Depressive Disorder (MDD) in children.

If you or a loved one took Prozac® and was injured, or displayed out-of-character destructive behavior, Prozac® lawyers can help you receive compensation for your suffering. Contact us today, and our Philadelphia Prozac® attorneys will review your case.